Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2341 - 2341
Published: Nov. 16, 2024
Recent
advances
have
highlighted
the
gut
microbiota
as
a
significant
contributor
to
development
and
progression
of
atherosclerosis,
which
is
an
inflammatory
cardiovascular
disease
(CVD)
characterized
by
plaque
buildup
within
arterial
walls.
The
microbiota,
consisting
diverse
collection
microorganisms,
impacts
host's
metabolism,
immune
responses,
lipid
processing,
all
contribute
atherosclerosis.
This
review
explores
complex
mechanisms
through
dysbiosis
promotes
atherogenesis.
We
emphasize
potential
integrating
modulation
with
traditional
care,
offering
holistic
approach
managing
Important
pathways
involve
translocation
microbial
components,
metabolism
metabolites
such
trimethylamine-N-oxide
(TMAO),
production
short-chain
fatty
acids
(SCFAs)
that
influence
vascular
health.
Studies
reveal
distinct
profiles
in
atherosclerosis
patients,
increased
pathogenic
bacteria
(
Gastrointestinal Disorders,
Journal Year:
2025,
Volume and Issue:
7(1), P. 7 - 7
Published: Jan. 15, 2025
The
human
microbiome,
a
complex
ecosystem
of
microorganisms
residing
in
and
on
the
body,
plays
pivotal
role
regulation
wide
range
physiological
processes,
including
digestion,
immune
responses,
metabolic
functions.
In
recent
years,
rapidly
growing
field
microbiome-driven
therapeutics
has
garnered
significant
attention
owing
to
its
potential
revolutionize
healthcare.
This
review
explores
evolving
landscape
microbiome-based
therapies,
with
particular
focus
gut
microbiome
implications
for
both
health
precision
medicine.
We
highlight
advances
understanding
how
microbial
communities
influence
disease
pathogenesis
treatment
outcomes,
spanning
conditions
such
as
inflammatory
bowel
(IBD),
disorders,
neurological
diseases,
even
cancer.
article
also
discusses
emerging
therapeutic
strategies,
probiotics,
prebiotics,
fecal
microbiota
transplantation
(FMT),
microbial-based
drugs,
well
challenges
associated
their
clinical
implementation.
Additionally,
we
examined
integration
profiling
metagenomic
data
is
advancing
medicine,
paving
way
personalized
effective
treatments.
serves
comprehensive
resource
that
synthesizes
current
knowledge,
identifies
key
gaps
research,
offers
insights
into
future
direction
therapeutics,
thus
providing
valuable
framework
clinicians,
researchers,
policymakers
seeking
harness
microbiomes
advance
healthcare
solutions.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 7, 2025
Anti-tumor
immunity,
including
innate
and
adaptive
immunity
is
critical
in
inhibiting
tumorigenesis
development
of
tumor.
The
needs
specific
lymph
organs
such
as
tertiary
lymphoid
structures
(TLSs),
which
are
highly
correlated
with
improved
survival
outcomes
many
cancers.
In
recent
years,
increasing
attention
on
the
TLS
tumor
microenvironment,
TLSs
have
emerged
a
novel
target
for
anti-tumor
therapy.
Excitingly,
studies
shown
contribution
to
immune
responses.
However,
it
unclear
how
form
more
effectively
defense
against
through
formation.
Recent
that
inflammation
plays
role
Interestingly,
also
found
gut
microbiota
can
regulate
occurrence
inflammation.
Therefore,
we
here
summarize
potential
effects
microbiota-
mediated
or
immunosuppression
formation
environments.
Meanwhile,
this
review
explores
manipulate
mature
regulating
microbiota/metabolites
associated
signal
pathways
potentially
lead
next-generation
cancer
immunotherapy.
Probiotics and Antimicrobial Proteins,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 8, 2024
Abstract
Probiotics
are
pivotal
in
maintaining
or
restoring
the
balance
of
human
intestinal
microbiota,
a
crucial
factor
mitigating
diseases
and
preserving
host’s
health.
Exploration
into
Bacteroides
spp.
reveals
substantial
promise
their
development
as
next-generation
probiotics
due
to
profound
interaction
with
host
immune
cells
capability
regulate
microbiome’s
metabolism
by
significantly
impacting
metabolite
production.
These
beneficial
bacteria
exhibit
potential
ameliorating
various
health
issues
such
disorders,
cardiovascular
diseases,
behavioral
even
cancer.
Though
it’s
important
note
that
high
percentage
them
well
opportunistic
pathogens,
posing
risks
under
certain
conditions.
Studies
highlight
role
modifying
responses
improving
conditions
regulating
lymphocytes,
controlling
metabolism,
preventing
inflammation
The
safety
efficacy
strains
currently
scrutiny
European
Commission
for
authorization
food
processing,
marking
significant
step
towards
commercialization.
recent
advancements
bacterial
isolation
sequencing
methodologies,
coupled
integration
Metagenome-Assembled
Genomes
(MAGs)
binning
from
metagenomics
data,
continue
unveil
spp.,
aiding
broader
understanding
application
these
novel
disease
management.
Fermentation,
Journal Year:
2024,
Volume and Issue:
10(9), P. 444 - 444
Published: Aug. 23, 2024
A
substantial
body
of
research
indicates
that
the
gut
microbiota
exerts
a
profound
influence
on
host
health.
The
purpose
this
work
was
to
characterize
selected,
most
promising,
well-known
next-generation
probiotics
(NGPs)
and
review
potential
applications
bacteria
in
food
technology.
isolation
with
significant
health
benefits
has
led
emergence
NGPs.
In
contrast
traditional
probiotics,
these
originate
directly
from
microbiota,
thereby
ensuring
their
optimal
adaptation
intestinal
ecosystem.
NGPs
exert
effects
organism
through
variety
mechanisms,
including
synthesis
bioactive
compounds,
modulation
metabolism
substances
provided
by
host.
Several
bacterial
species
have
been
identified
as
candidates
for
NGPs,
Akkermansia
muciniphila,
Faecalibacterium
prausnitzii,
Bacteroides
thetaiotaomicron,
Christensenella
minuta,
many
others.
These
demonstrated
capacity
beneficial
effects,
reduction
obesity,
type
2
diabetes,
metabolic
disorders,
even
cancers.
greatest
limitation
commercialization
is
lack
oxygen
tolerance,
which
presents
challenges
not
only
but
also
application
food.
approach
appears
be
microencapsulation.
Further
required
establish
safety
NGP
supplementation
protect
them
environmental
conditions.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 9, 2024
The
gut
microbiota
offers
numerous
benefits
to
the
human
body,
including
promotion
of
nutrient
absorption,
participation
in
metabolic
processes,
and
enhancement
immune
function.
Recent
studies
have
introduced
concept
gut-organ
axis,
which
encompasses
interactions
such
as
gut-brain
gut-liver
gut-lung
axis.
This
underscores
complex
interplay
between
various
organs
tissues,
brain,
heart,
lungs,
liver,
kidneys,
muscles,
bones.
Growing
evidence
indicates
that
can
influence
onset
progression
multi-organ
system
diseases
through
their
effects
on
Traditional
Chinese
medicine
has
demonstrated
significant
efficacy
regulating
gastrointestinal
system,
leveraging
its
unique
advantages.
Considerable
advancements
been
made
understanding
role
axis
within
mechanisms
action
traditional
medicine.
review
aims
elucidate
roles
health,
explore
potential
connections
microbiota,
examine
therapeutic
microbiota-gut-organ
Furthermore,
addresses
limitations
challenges
present
current
research
while
proposing
directions
for
future
investigations
this
area.
Journal of Translational Autoimmunity,
Journal Year:
2025,
Volume and Issue:
10, P. 100269 - 100269
Published: Jan. 8, 2025
Autoimmune
rheumatic
diseases
(ARDs)
are
a
heterogeneous
group
of
conditions
characterized
by
excessive
and
misdirected
immune
responses
against
the
body's
own
musculoskeletal
tissues.
Their
exact
aetiology
remains
unclear,
with
genetic,
demographic,
behavioural
environmental
factors
implicated
in
disease
onset.
One
prominent
hypothesis
for
initial
breach
tolerance
(leading
to
autoimmunity)
is
molecular
mimicry,
which
describes
structural
or
sequence
similarities
between
human
microbial
proteins
(mimotopes).
This
similarity
can
lead
cross-reactive
antibodies
T-cell
receptors,
resulting
an
response
autoantigens.
Both
commensal
microbes
microbiome
pathogens
trigger
thereby
potentially
contributing
onset
ARDs.
In
this
review,
we
focus
on
role
mimicry
rheumatoid
arthritis
systemic
lupus
erythematosus.
Moreover,
implications
also
briefly
discussed
ankylosing
spondylitis,
sclerosis
myositis.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 4, 2025
Abstract
Bacteroidota,
a
diverse
phylum
of
bacteria,
are
increasingly
recognized
for
their
significant
contributions
to
host
health,
particularly
through
antimicrobial
and
probiotic
properties.
This
study
investigates
the
functional
diversity
potential
42
new
Bacteroidota
strains
enriched
identified
from
hosts,
including
mouse
ceca
human
stool
samples.
Using
16S
rRNA
gene
sequencing,
we
phylogenetically
characterized
genera
Bacteroides,
Phocaeicola
Sphingobacterium
assessed
properties
related
potential.
The
were
evaluated
concerning
ability
inhibit
biofilm
formation
WHO
declared
clinically
pathogens,
gram-positive
Staphylococcus
aureus
epidermidis
,
gram-negative
Klebsiella
oxytoca
Pseudomonas
aeruginosa
eukaryotic
fungus
Candida
albicans.
Additionally,
investigated
bile
salt
hydrolase
quorum
quenching
activities
strains,
key
traits
associated
with
efficacy.
Our
findings
demonstrate
that
all
examined
consistently
exhibit
capacity
but
different
extent.
Furthermore,
14
showed
activity,
39
highlighting
High
inhibition
as
well
activity
against
both
autoinducers,
AHL
AI-2,
predominantly
observed
in
Bacteroides
caecimuris
muris
making
them
attractive
candidates
next-generation
probiotics.
Overall,
this
advances
field
probiotics
by
identifying
promising
therapeutic
applications
potentially
revolutionizing
approaches
microbiome-based
interventions
pathogen
control
clinical
settings.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1058 - 1058
Published: Jan. 26, 2025
Probiotic
bacteria
are
normal
inhabitants
of
a
healthy
human
gut,
conferring
multiple
beneficial
effects
on
the
gut
and
beyond.
Under
various
disease
states,
abundance
diversity
significantly
decreased,
process
called
dysbiosis.
Among
intra-
extracellular
components
probiotics,
vesicles
(EVs)
secreted
by
them
have
recently
garnered
significant
attention
as
potential
mediators
probiotics’
host
health.
Further,
these
nanosized
particles
that
encapsulate
wide
range
bioactive
molecules
(proteins,
lipids,
RNA,
DNA)
standing
out
key
factors
could
mediate
microbiota–host
communication
confer
ameliorating
in
experimental
inflammatory,
metabolic,
cardiovascular
models.
However,
standard
protocol
EV
isolation
from
probiotic
bacteria,
not
varying
lab
to
lab,
must
be
established
achieve
consistency
results
pre-clinical
Our
current
study
compared
two
commonly
used
methods
for
biological
samples,
ultracentrifugation
precipitation,
develop
isolating
EVs
probiotics
Lactobacillus
acidophilus
(LA),
Gram-positive
bacterium,
Escherichia
coli
Nissle
(EcN),
Gram-negative
bacterium.
The
method
gave
~1.5-fold
higher
yield
both
LA
EcN
precipitation
method.
released
level
LA.
were
quantified
characterized
nanoparticle-tracking
analysis
(NTA)
measuring
specific
surface
biomarkers
using
Western
blot.
Here,
we
describe
our
standardized
step-by-step
their
characterization.